MétaCan
Menu
Back to cohort

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

2008· article· en· W1972676137 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueBritish Journal of Clinical Pharmacology · 2008
Typearticle
Languageen
FieldMedicine
TopicSchizophrenia research and treatment
Canadian institutionsCentre for Addiction and Mental HealthBristol-Myers Squibb (Canada)Baycrest HospitalUniversity of Toronto
FundersJanssen PharmaceuticalsNational Cancer InstituteGlaxoSmithKlinePfizerNational Institute of Mental HealthEli Lilly and Company
KeywordsRisperidoneCYP2D6Paliperidone PalmitateNONMEMPopulationPharmacologyPharmacokineticsMedicineConcomitantInternal medicineAntipsychoticPsychiatrySchizophrenia (object-oriented programming)Cytochrome P450

Abstract

fetched live from OpenAlex

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Risperidone metabolism is affected by blocking CYP2D6 and CYP3A4 (in CYP2D6 poor metabolizers) metabolizing enzymes. • Age affects risperidone disposition and renal function affects elimination of 9‐hydroxy‐risperidone (primary active metabolite). WHAT THIS STUDY ADDS • The detection of a systematic shift in estimated apparent clearance in the African‐American population (it is not clear if there are biological or sociological contributors), and a shift in the clearance rate of risperidone based on concomitant administration of paroxetine, manifested as a change in assignment to a different metabolizer subpopulation group that may be primarily related to CYP2D6 metabolizer status. • The study shows an age‐related decrement in 9‐hydroxy‐risperidone clearance across a wide range of ages. • Information on the nature of the pharmacokinetic variability with risperidone when used in a typical clinical patient population. • There are significant differences in the absolute values as well as the assignment to metabolizer status across race and concomitant paroxetine administration. AIMS To characterize pharmacokinetic (PK) variability of risperidone and 9‐OH risperidone using sparse sampling and to evaluate the effect of covariates on PK parameters. METHODS PK analysis used plasma samples collected from the Clinical Antipsychotic Trials of Intervention Effectiveness. A nonlinear mixed‐effects model was developed using nonmem to describe simultaneously the risperidone and 9‐OH risperidone concentration–time profile. Covariate effects on risperidone and 9‐OH risperidone PK parameters were assessed, including age, weight, sex, smoking status, race and concomitant medications. RESULTS PK samples comprised 1236 risperidone and 1236 9‐OH risperidone concentrations from 490 subjects that were available for analysis. Ages ranged from 18 to 93 years. Population PK submodels for both risperidone and 9‐OH risperidone with first‐order absorption were selected to describe the concentration–time profile of risperidone and 9‐OH risperidone. A mixture model was incorporated with risperidone clearance (CL) separately estimated for three subpopulations [poor metabolizer (PM), extensive metabolizer (EM) and intermediate metabolizer (IM)]. Age significantly affected 9‐OH risperidone clearance. Population parameter estimates for CL in PM, IM and EM were 12.9, 36 and 65.4 l h −1 and parameter estimates for risperidone half‐life in PM, IM and EM were 25, 8.5 and 4.7 h, respectively. CONCLUSIONS A one‐compartment mixture model with first‐order absorption adequately described the risperidone and 9‐OH risperidone concentrations. Age was identified as a significant covariate on 9‐OH risperidone clearance in this study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.036
Threshold uncertainty score0.575

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.389
GPT teacher head0.507
Teacher spread0.117 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it